These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 6110672)

  • 21. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP; Amr S; Carayon P; Nisula BC
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH; Gerend PL; Goretzki P; Nissenson RA
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease.
    Heyma P; Harrison LC; Robins-Browne R
    Clin Exp Immunol; 1986 May; 64(2):249-54. PubMed ID: 3017619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
    Iitaka M; Tanikawa T; Sakatsume Y; Yanagisawa M; Hara Y; Ishii J
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody.
    Kotulla P; Schleusener H
    J Endocrinol Invest; 1981; 4(2):155-60. PubMed ID: 6268690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of immunoglobulin G from patients with autoimmune thyroid diseases to solubilized guinea pig fat cell membranes crosslinked with 125I-TSH.
    Iida Y; Konishi J; Misaki T; Kasagi K; Endo K; Kuma K; Torizuka K
    Endocrinol Jpn; 1986 Jun; 33(3):333-43. PubMed ID: 2428605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Both TSH and thyroid-stimulating antibody of Graves' disease bind to an Mr 197,000 holoreceptor.
    Islam MN; Briones-Urbina R; Bakó G; Farid NR
    Endocrinology; 1983 Jul; 113(1):436-8. PubMed ID: 6134614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
    Strakosch CR; Joyner D; Manley SW; Wall JR
    Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of the mouse thyrotrophin receptor with thyrotrophin binding inhibitor immunoglobulins.
    Luttrell BM
    J Endocrinol; 1983 Mar; 96(3):481-8. PubMed ID: 6131925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of triton-solubilized TSH receptors from human thyroid plasma membranes.
    Iida Y; Konishi J; Kasagi K; Ikekubo K; Kuma K; Torizuka K
    Acta Endocrinol (Copenh); 1981 Sep; 98(1):50-6. PubMed ID: 6269343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipocyte-TSH-receptor-related antibodies in Graves' disease detected by immunoprecipitation.
    Konishi J; Iida Y; Kasagi K; Ikekubo K; Kuma K; Torizuka K
    Endocrinol Jpn; 1982 Apr; 29(2):219-26. PubMed ID: 6127208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive regulation of the guinea pig thyrotropin receptor.
    Davies TF
    Endocrinology; 1985 Jul; 117(1):201-7. PubMed ID: 2988915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
    de Bruin TW; van der Heide D
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photoaffinity labelling of the porcine thyrotropin receptor--effect of Graves' immunoglobulin G and anti-TSH anti-idiotypic antibodies.
    Bakó G; Islam MN; Farid NR
    Clin Invest Med; 1985; 8(2):152-9. PubMed ID: 2870832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action.
    Ochi Y; Hachiya T; Koyama Y; Fukuhori N; Ashida N
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):508-512. PubMed ID: 29468987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
    Carayon P; Adler G; Roulier R; Lissitzky S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
    J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.